AbCellera Biologics Inc (ABCL) Company Profile & Statistics

AbCellera Biologics Inc
ABCL
(Nasdaq - US)
N/A
3.86
+0.08 (+1.98%)
in:usd•As of: May 02, 2024 15:59 UTC -4
Open
3.84
High
3.86
Low
3.69

About AbCellera Biologics Inc

CEO

Carl L. G. Hansen

Headquarters

2215 yukon street

vancouver, a1 v5y 0a1, canada

Auditor

KPMG LLP

Employees

586

Share Holders

Website

www.abcellera.com

Industry

biotechnology

Sector

health technology

Company Overview

AbCellera Biologics Inc. is a technology company which searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera Biologics Inc. is based in Vancouver, Canada.

AbCellera Biologics Inc Statistics

Valuation Measures

Market Capitalization ²	1.13B
Enterprise Value	974.74M
Enterprise Value/EBITDA (ttm)	-4.72
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.95
Price to Sales (ttm)	29.22
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-384.99%
Profit Margin (ttm)	-394.96%
Return on Equity (ttm)	-12.36%
Return on Invested Capital (ttm)	-12.38%
Return on Assets (ttm)	-9.70%

Income Statement

Revenue (ttm)	38.02M
Revenue Per Share (ttm)	0.13
Gross Profit (ttm)	38.02M
EBITDA (ttm)³	-206.31M
Net Income Avi to Common (ttm)	-146.40M
Diluted EPS (ttm)	-0.52

Share Statistics

Beta (5Y Monthly)	0.42
52-Week Change	-40.33%
S&P500 52-Week Change	24.66%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	292.78M
Dividend Yield	0.00%
Float ⁴	197.77M
% Held by Insiders	32.45%
% Held by Institutions	61.42%

Balance Sheet

Total Cash (mrq)	785.59M
Total Cash Per Share (mrq)	2.68
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.33%
Quick Ratio (mrq)	7.33%
Book Value Per Share (mrq)	3.96

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.15
Free Cash Flow (ytd)	-120.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AbCellera Biologics Inc

Trade With A Regulated Broker